RxDoctor Payments Data

Sandra Rincon, MD

Neuroradiology · Boston, MANPI 1215927447

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,980 of the $11,980 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Merck. Reporting peaked in 2019 at $6,145 and has fallen 72.6% since, to $1,685 in 2021.

$11,980in general payments, 2019–2025

Across 27 payments — averaging $443.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$12K
$142,473in research payments, 2019–2025

Across 31 payments — averaging $4595.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$85K
  • Takeda Pharmaceuticals U.S.A., Inc.$41K
  • Novartis$15K
  • EMD Serono, Inc.$790
  • Regeneron$75

What the payments were for

  • Consulting fees$11,980100%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck27$11,980

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,980 in reported general payments places this provider in the 70th percentile of 35 neuroradiology providers in Massachusetts.

See all neuroradiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$121,389
Medicare patients
1,458
Services billed
4,655

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuroradiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →